SH2-containing inositol-5′-phosphatase-1 (SHIP-1) controls the phosphatidylinositol-3′-kinase (PI3K) initiated signaling pathway by limiting cell membrane recruitment and activation of Akt. Despite the fact that many of the growth factors important to cartilage development and functions are able to activate the PI3K signal transduction pathway, little is known about the role of PI3K signaling in chondrocyte biology and its contribution to mammalian skeletogenesis. Here, we report that the lipid phosphatase SHIP-1 regulates chondrocyte hypertrophy and skeletal development through its expression in osteochondroprogenitor cells. Global SHIP-1 knockout led to accelerated chondrocyte hypertrophy and premature formation of the secondary ossification center in the bones of postnatal mice. Drastically higher vascularization and greater number of c-kit + progenitors associated with sinusoids in the bone marrow also indicated more advanced chondrocyte hypertrophic differentiation in SHIP-1 knockout mice than in wild-type mice. In corroboration with the in vivo phenotype, SHIP-1 deficient PDGFRα + Sca-1 + osteochondroprogenitor cells exhibited rapid differentiation into hypertrophic chondrocytes under chondrogenic culture conditions in vitro. Furthermore, SHIP-1 deficiency inhibited hypoxia-induced cellular activation of Akt and extracellular-signal-regulated kinase (Erk) and suppressed hypoxia-induced cell proliferation. These results suggest that SHIP-1 is required for hypoxia-induced growth signaling under physiological hypoxia in the bone marrow. In conclusion, the lipid phosphatase SHIP-1 regulates skeletal development by modulating chondrogenesis and the hypoxia response of the osteochondroprogenitors during endochondral bone formation. K E Y W O R D S bone marrow microenvironment, chondrocyte hypertrophy, lipid phosphatase SHIP-1, osteochondral progenitor cells, skeletal development ---This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. SUPPORTING INFORMATION Additional supporting information may be found online in the Supporting Information section. How to cite this article: So E-Y, Sun C, Wu KQ, et al. Lipid phosphatase SHIP-1 regulates chondrocyte hypertrophy and skeletal development.
| INTRODUCTION
Skeletal development begins in the embryo when multipotent mesenchymal cells arise from the ectoderm and mesoderm, migrate to specific sites and commit to a skeletal fate. While most skeletogenic progenitors will differentiate into chondrocytes to form cartilage and later into osteoblasts to form bone, some remain as mesenchymal stem cells (MSCs) in the bone marrow (BM) throughout life (Kobayashi & Kronenberg, 2014) . The primary skeleton, which is entirely cartilaginous, will progressively transform into bone during fetal and postnatal growth through a developmental process known as endochondral ossification (Mackie, Ahmed, Tatarczuch, Chen, & Mirams, 2008) . During endochondral bone formation, chondrocytes undergo proliferation, hypertrophic differentiation and apoptosis (Stevens & Williams, 1999) . Blood vessel invasion is accompanied by an influx of osteoblastic progenitors from the perichondrium resulting in the replacement of cartilage with bone (Kronenberg, 2003; Long & Ornitz, 2013; Maes et al., 2010) . A corollary of the complexity of the skeletal development is a high incidence of osteochondrodysplasia at a young age, which often constitutes high risk for skeleton degenerative diseases such as osteoarthritis and osteoporosis later in life (Lefebvre & Bhattaram, 2010; Long & Ornitz, 2013) . Thus, elucidating the biological processes that control endochondral bone development is critical for understanding human skeletal dysplasia and adult abnormal fracture healing.
Despite the fact that many of the growth factors important to cartilage development and functions are able to activate the phosphatidylinositol-3′-kinase (PI3K) signal transduction pathway, little is known about the role of PI3K signaling in chondrocyte biology and its contribution to mammalian skeletogenesis (Guntur & Rosen, 2013; Kita, Kimura, Nakamura, Yoshikawa, & Nakano, 2008; Ulici et al., 2009) . Specific ligand-receptor interactions recruit PI3K into proximity with its substrate phosphatidylinositol (4,5)-bisphosphate, PI(4,5)P2, to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate, PI (3, 4, 5) P3. SH2-containing inositol-5′-phosphatase-1 (SHIP-1) hydrolyzes PI (3, 4, 5) P3 to PI(3,4)P2. Both PI(3,4,5)P3 and PI(3,4)P2 have a significant affinity for pleckstrin homology domain-containing kinases (e.g. Akt) that serve as effectors of PI3K signaling (Franke, Kaplan, Cantley, & Toker, 1997; Rohrschneider, Fuller, Wolf, Liu, & Lucas, 2000) . Unlike the 3′-phosphatase and tumor suppressor PTEN, which primarily controls the levels of PI(3,4,5)P3 (Song, Salmena, & Pandolfi, 2012) , the 5′-phosphatase SHIP-1 modulates PI3K initiated signaling by limiting membrane recruitment and activation of Akt through both its substrate PI(3,4,5)P3 and its product PI(3,4)P2 (Fernandes, Iyer, & Kerr, 2013; Ma, Cheung, Marshall, & Duronio, 2008; Scheid et al., 2002) . While inactivation of PTEN in osteochondroprogenitor cells results in epiphyseal growth plate abnormalities and skeletal overgrowth (Ford-Hutchinson et al., 2007) , global deletion of SHIP-1 in mice leads to severe osteoporosis reportedly due to increased numbers of hyper-resorptive osteoclasts (Takeshita et al., 2002) . However, a recent report by Iyer, Viernes, Chisholm, Margulies, and Kerr (2014) demonstrated that mice with myeloid-restricted ablation of SHIP-1, including osteoclasts, show no reduction in bone mass or density. The study suggests that bone mass reduction of the knockout mice is mainly due to SHIP-1 deficiency in MSCs and osteolineage progenitors. Previous studies by Hazen et al. (2009) show that SHIP-1 is expressed by stromal cells and regulates their differentiation and support of the hematopoietic stem cells. Selective ablation of SHIP-1 in MSCs causes the skeletal defects observed in germline null mice, further demonstrating that SHIP-1 is expressed by MSCs and regulates their self-renewal and differentiation (Iyer et al., 2014) . We recently discovered that deficiency of the lipid phosphatase SHIP-1 could enable long-term reconstitution of the hematopoietic BM microenvironment (Liang et al., 2013) . However, the mechanism with which SHIP-1 is required for a functional hematopoietic niche remains unclear. Here, we report that SHIP-1 plays a critical role in skeletal development, where in the absence of SHIP-1, accelerated chondrocyte hypertrophy and increased vascularization leads to reduced skeletal size, altered bone architecture, and BM microenvironment.
| MATERIALS AND METHODS

| Mouse maintenance and genotyping
Animal procedures followed protocols approved by the Institutional Animal Care and Use Committees at Rhode Island Hospital. The SHIP-1 KO mice (Inpp5d < tm1Dmt > /J, Stock Nr. 003534) of a mixed genetic background (129/C57BL/6) were purchased from the Jackson Laboratory (Bar Harbor, ME) and backcrossed with C57BL/6 mice (C57BL/6 J, Stock Nr. 000664) for multiple generations. Mouse genotyping was carried out following protocols from the Jackson Laboratory.
| Histology and immunohistochemistry
For histological analyses, the hind limbs of the postnatal mice were dissected, fixed in 10% formalin solution in neutral buffer. Paraffin sections were prepared following standard procedures. For morphological evaluation, the sections were stained with Safranin-O/Fast Green using 1% Safranin-O solution with counterstaining by hematoxylin and 0.2% Fast Green. For collagen type X (Col X) immunohistochemical (IHC) staining, the sections were deparaffinized with xylene and rehydrated in a descending series of ethanol concentrations. Heatmediated antigen retrieval was performed using 1 x citrate buffer (pH 6.0). The deparaffinized and rehydrated sections were blocked and incubated with 1:150 dilution of the anti-collagen type X antibody (purified mouse monoclonal X53, 14-9771-82, ThermoFisher, Waltham, MA) overnight at 4°C. Slides were then incubated with the EnVision Dual Link System-HRP solution (Dako, Santa Clara, CA) containing goat anti-mouse and anti-rabbit immunoglobulins conjugated to the peroxidase-labeled polymer. Following chromogenic development, the slides were counterstained with Harri's hematoxylin.
Images were taken by using a Nikon Eclipse E800 microscope equipped with a camera and SPOT software (SPOT Imaging, Sterling Heights, MI).
| Immunofluorescent staining and laser-scanning cytometry of BM sections
Laser-scanning cytometry was performed as described earlier . Briefly, the mice were perfused post-mortem with 10 ml paraformaldehyde-lysine-periodate (PLP) fixative through the vena cava to achieve rapid in situ fixation and optimal preservation of the BM tissue. Femoral bones were isolated, fixed in PLP for 4-8 hr, rehydrated in 30% sucrose/phosphate- 
| PDGFRα + Sca-1 + (PαS) MSC isolation and cultivation
Murine BM PαS MSCs from WT and SHIP-1 KO mice (6-week old) were isolated and cultured using reagents and methods as previously described by Morikawa et al. (2009) . Briefly, femurs and tibias from WT or SHIP-1 KO mice were dissected and crushed with mortar and pestle. The bone fragments were gently washed once in HBSS supplemented with 2% fetal bovine serum (FBS), 10 mM Hepes, and 1% penicillin/streptomycin (P/S). The cell suspension filtered through a 70 μm cell strainer (BD Falcon) was discarded. The bone fragments were incubated for 1 hr at 37°C in 20 ml DMEM (Invitrogen) containing 0.2% collagenase (Wako Chemicals), 10 mM Hepes, and 1% P/S. The cell suspension was filtered through a cell strainer to remove debris and bone pieces, and cells were collected by centrifugation at 280g for 7 min at 4°C. The pellet was immersed in 1 ml water for 5-10 s to burst the red blood cells, after which 1 ml of 2 × PBS containing 4% FBS was added, and the suspension was filtered through a cell strainer. The cells were suspended in ice-cold HBSS containing supplements as above at 1-5 × 10 7 cell/ml, and stained for 30 min on ice with the following antibodies APC-PDGFRα (APA5), FITC-Sca-1 (Ly6A/E), PE-CD45 (30-F11), and PE-Ter119 (Ter-119) (all from eBioscience). Flow cytometry analysis and sorting were performed on a Beckman Coulter MoFlo Legacy with software Summit version 4.3. The CD45-, Ter119-, PDGFRα+, and Sca-1+ (PαS) cells were allowed to adhere to the plastic surface of a 25 cm 2 tissue culture flask (Falcon 3081) for 48 hr without disturbance in α-MEM medium (Invitrogen) supplemented with 10% nonheatinactivated FBS (Hyclone), 10% horse serum (Sigma), 1x L-Glutamine (Invitrogen) and 1% P/S (Peister et al., 2004) .
| PαS MSC proliferation assay
Proliferation of PαS MSCs was measured using a 3-(4,5-demethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay kit (Cayman Chemical) according to the manufacturer's instruction. In brief, the cells were seeded at a density of 5 × 10 3 per well in a 96-well plate in 100 μl of complete medium in a regular CO 2 incubator or in a hypoxia chamber. At the indicated time points, 100 μl MTT reagent was added into each well, and then formazan crystals were extracted by crystal dissolving solution. Absorbance was measured with a microplate reader at 570 nm (Molecular Devices).
| Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting
PαS MSC total cell lysates were prepared in M-PER lysis buffer (Thermo Fisher Scientific) plus protease inhibitor cocktail (Halt, Thermo Fisher Scientific), and separated by using an 8.0% SDS polyacrylamide gel. Protein transfer onto a polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Millipore) was carried out in a semidry transfer unit (Trans-Blot, Bio-Rad) in 25 mM Tris, 192 mM Glycine, and 20% methanol for 30 min to 1 hr at 20 V. Membranes were blocked in 5% nonfat dried milk in Tris-buffered saline (TBS)/ 0.1% Tween-20 and incubated with primary antibodies and then fluorescence-labeled secondary antibodies (LI-COR Biotechnology), followed by scanning on a fluorescence image reader (Odyssey, LI-COR Biotechnology). Primary antibodies used in this study were anti-Akt, anti-Erk (Cell Signalling Technology), and anti-hypoxiainducible factor-1α (anti-HIF-1α; Cayman Chemical). Specific antiphosphorylation antibodies were used against phospho-Akt (Ser473) and phospho-Erk (Thr202/Tyr204) (Cell Signaling). Anti-β-actin antibody (Novus) was used to detect β-actin as loading controls.
| Chondrogenic differentiation of PαS MSCs
Chondrogenic differentiation of PαS cells was carried out using Mouse StemXVivo Base Media and Chondrogenic Supplement according to the manufacturer's recommendation (CCM005 and CCM006; R&D Systems).
Briefly, approximately 2.5 × 10 5 PαS MSCs were resuspended in 5 ml of the pre-warmed completed StemXVivo Base Media. The cells were centrifuged at 200g for 5 m at room temperature, followed by aspiration of the media and resuspension of the cells in 0.5 ml of pre-warmed completed StemXVivo Chondrogenic Differentiation Media. The cells were then spun down again and the cell pellets were allowed to incubate upright with the chondrogenic differentiation medium at 37°C and 5% CO 2 for 21 days, with fresh medium every 3 days. The chondrogenic pellets were then fixed with 10% formalin (Sigma), paraffin embedded, and sectioned for hematoxylin and eosin (H&E) staining and immunohistochemistry. Chondrocyte differentiation was verified by using a sheep SO ET AL.
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anti-mouse collagen type II (Col II) polyclonal antibody (AF3615; R&D Systems), which was then visualized by using a NorthernLights 557conjugated Donkey Anti-Sheep Secondary Antibody (NL010; R&D Systems). Hypertrophic chondrocyte differentiation was verified by using a mouse anti-collagen type X (Col X) monoclonal antibody (X53) conjugated with eFluor 570, (41-9771-82; Thermo Fisher Scientific).
The nuclei were counterstained with DAPI (Biolegend). Images were taken with a Nikon Eclipse E800 fluorescence microscope equipped with a camera and SPOT software. 
| Gene expression analysis of SHIP-1 KO PαS MSCs
To determine the gene expression pattern of WT and SHIP-1 KO PαS 
| Defective skeleton and BM microenvironment in adult mice deficient of SHIP-1
Since terminally differentiated hypertrophic chondrocytes effectively attract blood vessel invasion and co-migrating osteoprogenitors from the perichondrium, we postulate that premature chondrocyte hypertrophy would contribute to an altered BM microenvironment in the SHIP-1 KO mice. Global SHIP-1 deletion led to a smaller skeletal stature in adult mice ( Figure S1a ). H&E staining of the distal femoral epiphysis revealed that SHIP-1 KO mice had thinner femoral cortical bones, augmented, thickened and disorganized trabeculae in a plate-like pattern rather than the rod-like pattern in WT mice ( Figure S1b,c) . To further determine the effect of SHIP-1 deficiency on vascularization of the bones, we performed laser-scanning cytometry (LSC) on femurs from both WT (Figure 3a ,c) and SHIP-1 KO mice (Figure 3b,d) . The apparent volume of the blood vessel as visualized by laminin staining in red was significantly higher in the SHIP-1 KO femur than in WT. Next, we examined whether the augmented vessel density in SHIP-1 KO BM may increase the influx of progenitor cells including osteochondroprogenitors. As shown in Figure 4 , a large number of c-kit + progenitor cells were associated with sinusoidal vessels in SHIP-1 deficient BM (Figure 4b,d) compared to WT BM (Figure 4a 
| Accelerated chondrocyte hypertrophy by SHIP-1 KO MSCs in vitro
The PDGFRα + Sca-1 + (PαS) MSCs were identified as a relatively homogenous subset of MSCs from the BM, and they can differentiate into osteoblasts, reticular cells and adipocytes in vivo once transplanted into irradiated mice (Morikawa et al., 2009) . A recent study suggests that the early osteochondroprogenitor marker Prx1 labels the PαS MSC population that is required for hematopoietic stem cell maintenance by producing CXCL12 and ANG-1 (Greenbaum et al., 2013) . Given these characteristics, we chose to study the PαS MSCs as a model Figure S2b) . These results suggest that SHIP-1 may have a role in regulating MSC growth in the BM depending on oxygen concentration in the microenvironment.
| Impaired cellular response to hypoxia by SHIP-1 KO PαS MSCs
MSCs reside in perivascular niches in the BM and in response to hypoxia express a number of genes associated with cell proliferation and survival (Mohyeldin, Garzon-Muvdi, & Quinones-Hinojosa, 2010; Ohnishi, Yasuda, Kitamura, & Nagaya, 2007; Spencer et al., 2014) .
Since SHIP-1 deficiency abrogates hypoxia-induced MSC proliferation, we examined protein expression of HIF-1α in PαS MSCs cultured under Nx or Hx conditions. It has been well established that Magnification, ×100. Scale bar = 50 μm. SHIP-1, SH2-containing inositol-5′-phosphatase-1; SOC, secondary ossification center; WT, wild-type hypoxia (<5% O 2 ) stabilizes the HIF-1α protein, which is critical for osteogenesis and joint development (Araldi & Schipani, 2010) . We found hypoxia-induced HIF-1α stabilization decreased in SHIP-1 KO MSCs (Figure 6a ). Furthermore, treatment with a selective SHIP-1 inhibitor 3α-aminocholestane (3AC) (Brooks et al., 2010) , also suppressed hypoxia-induced stabilization of HIF-1α protein in WT MSCs (Figure 6b ), suggesting SHIP-1 is a key factor for cellular response to hypoxia in MSCs.
| SHIP-1 is required for hypoxia-induced growth signaling in MSCs
It has been reported that SHIP-1 activity is required to suppress PIP3-induced Akt activation in multiple cell types, including neutrophils and MSCs, and SHIP-1 regulates osteolineage commitment of MSCs through limiting induction of the PI3K/ Akt/Id2 signaling pathway (Iyer et al., 2014; Mondal et al., 2012) .
Here, we investigate whether SHIP-1 contributes to the activation of growth signaling in MSCs. WT and SHIP-1 KO MSCs were cultured under normoxia or hypoxia (Figure 6a ), or in the presence of deferoxamine (DFO), a hypoxia-mimicking chemical (Figure 6c,d) . The expression of Akt, Erk and their activation (phosphorylation) status were examined by immunoblotting. We found less induction of Akt phosphorylation in SHIP- Akt and Erk phosphorylation were well-established as a proliferative response to growth factors and stresses in many cell types (Zhang & Liu, 2002) . These results suggest that reduced stability of HIF-1α combined with impaired activation of both Akt 
| Differential gene expression in WT and SHIP-1 KO PαS MSCs under hypoxia
In addition, we also performed gene expression profiling on SHIP-1 KO PαS MSCs and compared the expression levels of 84 key genes with those of the WT PαS MSCs after these cells were exposed to hypoxia treatment for 48 hr. The heat map generated by the Qiagen PCR Array Data Analysis software shows a fold change that represents relative mRNA expression for SHIP-1 KO PαS MSCs compared with WT cells ( Figure S4a ). Significantly 
| DISCUSSION
Much of the mammalian skeleton is composed of bones that originate from cartilage templates through the process of endochondral bone formation. The transition from cartilage to bone is tightly coupled with chondrocyte proliferation, hypertrophy, blood vessel invasion and osteoblast differentiation in a temporal and spatial specific manner (Aguila & Rowe, 2005; Kobayashi & Kronenberg, 2014; Kronenberg, 2003; Maes, Carmeliet, & Schipani, 2012) . Unlike the 3′-phosphatase and tumor suppressor PTEN, which primarily controls the levels of PI(3,4,5)P3 (Song et al., 2012) , the 5′-phosphatase SHIP-1 modulates PI3K initiated signaling by limiting membrane recruitment and activation of Akt through both its substrate PI(3,4,5)P3 and its product PI(3,4)P2 (Fernandes et al., 2013; Ma et al., 2008; Scheid et al., 2002) . , 4, or 7 hr (d) . Total protein extracts were prepared and subjected to western blot analysis using the indicated antibodies, and β-actin was used as an internal loading control. (e and f) Immunohistochemical (IHC) staining of phosphorylated Akt in cells of WT and SHIP-1 KO BM was performed, and plenty of IHC staining signals (black dots) could be visualized in the WT BM but none in the SHIP-1 KO BM. Magnification: ×200 (e and f). Scale bar = 50 μm. BM, bone marrow; DFO, deferoxamine; Erk, extracellular-signal-regulated kinase; HIF-1α, hypoxia-inducible factor-1α; Hx, hypoxia; IHC, immunohistochemical; MSC, mesenchymal stem cell; Nx, normoxia; SHIP-1, SH2-containing inositol-5′phosphatase-1; WT, wild-type of phospho-Akt driven proliferation. Instead, we postulate that the influx of these progenitor cells is due to enhanced vessel invasion, which follows chondrocyte hypertrophy.
Since chondrocyte hypertrophic differentiation precedes blood vessel invasion and osteoprogenitor influx (Maes et al., 2010; Sacchetti et al., 2007) , accelerated differentiation into hypertrophic chondrocytes by SHIP-1 KO MSCs likely contributes to the greater vessel density and increased number of progenitor cells in the BM. We believe that osteoclasts may also play a role in the observed phenotype, which warrants further studies. We further speculate that excessive vessel invasion may deplete the osteoblastic progenitor pool of the perichondrium, resulting in thinner cortical bones, and augmented and disorganized trabeculae formation in the BM. The nature of the cellular and molecular mechanisms responsible for coupling angiogenesis and skeletal development remains poorly understood, but a primary driving force is tissue hypoxia (Schipani et al., 2001) . (Caldwell & Wang, 2015; Doran, 2015) . Our current study has shed some light on the chondrocyte hypertrophy during endochondral ossification and suggests that SHIP-1 may be a critical player regulating the cartilage formation process. It would be interesting to investigate whether overexpression of SHIP-1 in MSCs or application of a small molecule agonist to enhance SHIP-1 activity (Viernes, Choi, Kerr, & Chisholm, 2014) would delay the chondrocyte hypertrophic process in an autologous chondrocyte implantation osteoarthritis animal model.
| CONCLUSION
In conclusion, the lipid phosphatase SHIP-1 exerts a critical role in skeletal development and in establishing the BM microenvironment through controlling chondrocyte hypertrophy and the hypoxia response of the osteochondroprogenitors. Further studies using chondrocyte and hypertrophic chondrocyte specific targeted deletion of SHIP-1 are warranted. Targeting SHIP-1 expression in vivo has the potential to treat human skeletal dysplasia and adult abnormal fracture healing and may improve the outcome of cell-based cartilage repair therapy.
